- Investing Ideas
- /
- U.S. High Growth Potential Companies
U.S. High Growth Potential Companies
Results
1531
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
1,531 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
AVGO | US$187.37 | -9.9% | 33.6% | US$934.8b | US$246.58 | PE142.4x | E29.5% | 1.3% | Semiconductors | ||
BA | US$170.06 | -5.5% | -15.2% | US$131.0b | US$195.81 | PS1.9x | E78.3% | 0% | Capital Goods | ||
NBIX | US$114.48 | -3.9% | -14.0% | US$11.8b | US$166.13 | PE33.4x | E27.2% | n/a | Pharmaceuticals & Biotech | ||
SBFM | US$2.31 | -1.3% | -98.6% | US$4.6m | US$300.00 | PS0.1x | E208.2% | n/a | Pharmaceuticals & Biotech | ||
BOW | US$34.59 | 9.9% | n/a | US$1.1b | US$37.20 | PE29.5x | E29.3% | n/a | Insurance | ||
FINW | US$19.45 | 3.7% | 112.6% | US$262.0m | US$21.67 | PB1.5x | E33.0% | n/a | Banks | ||
BRTX | US$1.51 | -5.6% | 7.9% | US$10.5m | US$13.00 | PS27.7x | E64.1% | n/a | Pharmaceuticals & Biotech | ||
CSLR | US$1.35 | -15.1% | 29.8% | US$108.4m | US$4.50 | PS2.4x | E68.5% | n/a | Capital Goods | ||
MNSO | US$19.88 | 1.7% | 8.8% | US$6.4b | US$25.64 | PE16.6x | E20.3% | 2.7% | Retail | ||
PFIS | US$48.13 | -0.3% | 21.6% | US$487.8m | US$60.00 | PB1x | E65.0% | 5.1% | Banks | ||
MSBI | US$19.31 | 2.1% | -18.7% | US$416.6m | US$22.50 | PB0.7x | E90.3% | 6.4% | Banks | ||
ARBE | US$1.71 | -17.8% | -8.2% | US$176.5m | US$4.00 | PS160.6x | E67.8% | n/a | Tech | ||
KRYS | US$171.83 | -8.1% | 7.4% | US$5.2b | US$211.44 | PE55.5x | E31.9% | n/a | Pharmaceuticals & Biotech | ||
SPR | US$34.75 | 2.1% | 1.2% | US$4.1b | US$36.65 | PS0.6x | E83.4% | 0% | Capital Goods | ||
ARDX | US$5.08 | -1.0% | -43.8% | US$1.3b | US$10.31 | PS3.6x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
DCOM | US$30.34 | -0.4% | 73.4% | US$1.4b | US$41.00 | PB1x | E71.6% | 3.3% | Banks | ||
GAMB | US$13.68 | -5.1% | 58.3% | US$498.8m | US$18.86 | PE16.5x | E21.0% | n/a | Media | ||
ENFN | US$11.37 | -0.6% | 32.2% | US$1.5b | US$10.93 | PE395x | E74.8% | n/a | Software | ||
CTXR | US$1.56 | -8.8% | -91.9% | US$14.2m | US$39.00 | PB0.2x | E62.3% | n/a | Pharmaceuticals & Biotech | ||
TLSI | US$5.65 | 2.5% | -42.5% | US$175.6m | US$11.44 | PS6.4x | E60.4% | n/a | Pharmaceuticals & Biotech | ||
LOB | US$31.21 | -2.4% | -17.1% | US$1.4b | US$41.00 | PB1.4x | E36.0% | 0.4% | Banks | ||
DDL | US$3.08 | -12.3% | 135.1% | US$758.4m | US$3.20 | PE24.6x | E40.7% | n/a | Consumer Retailing | ||
OTLK | US$1.42 | -6.6% | -83.2% | US$48.0m | US$10.00 | PE-1x | E61.9% | n/a | Pharmaceuticals & Biotech | ||
MDAI | US$1.59 | -15.0% | -21.3% | US$33.9m | US$5.12 | PS1.1x | E45.3% | n/a | Healthcare |